AVN 72.11 Increased By ▲ 0.69 (0.97%)
BOP 9.04 Increased By ▲ 0.02 (0.22%)
CHCC 136.40 Increased By ▲ 0.23 (0.17%)
DCL 9.75 Increased By ▲ 0.08 (0.83%)
DGKC 106.74 Decreased By ▼ -0.06 (-0.06%)
EFERT 61.40 Decreased By ▼ -0.09 (-0.15%)
EPCL 45.64 Increased By ▲ 0.34 (0.75%)
FCCL 21.46 Decreased By ▼ -0.02 (-0.09%)
FFL 15.10 No Change ▼ 0.00 (0%)
HASCOL 15.26 Increased By ▲ 0.10 (0.66%)
HBL 129.98 Decreased By ▼ -0.13 (-0.1%)
HUBC 84.54 Decreased By ▼ -0.01 (-0.01%)
HUMNL 6.04 No Change ▼ 0.00 (0%)
JSCL 28.37 Decreased By ▼ -0.13 (-0.46%)
KAPCO 28.62 Increased By ▲ 0.02 (0.07%)
KEL 3.69 Increased By ▲ 0.03 (0.82%)
LOTCHEM 13.20 Increased By ▲ 0.04 (0.3%)
MLCF 40.95 Decreased By ▼ -0.02 (-0.05%)
OGDC 102.95 Increased By ▲ 0.05 (0.05%)
PAEL 34.70 No Change ▼ 0.00 (0%)
PIBTL 12.83 Decreased By ▼ -0.02 (-0.16%)
PIOC 95.43 No Change ▼ 0.00 (0%)
POWER 9.70 No Change ▼ 0.00 (0%)
PPL 92.83 Increased By ▲ 0.01 (0.01%)
PSO 206.80 Increased By ▲ 0.04 (0.02%)
SNGP 44.23 Decreased By ▼ -0.07 (-0.16%)
STPL 16.00 Decreased By ▼ -0.25 (-1.54%)
TRG 72.95 Decreased By ▼ -0.36 (-0.49%)
UNITY 27.36 Increased By ▲ 0.05 (0.18%)
WTL 1.10 Increased By ▲ 0.05 (4.76%)
BR100 4,399 Increased By ▲ 24.17 (0.55%)
BR30 22,249 Increased By ▲ 134.76 (0.61%)
KSE100 42,207 Increased By ▲ 159.28 (0.38%)
KSE30 17,683 Increased By ▲ 17.86 (0.1%)

BEIJING: Pakistan, China will jointly build a cancer medical laboratory through cooperative partnership.

In this connection, an agreement’s signing ceremony of Pakistan-China biotechnology strategic cooperation was held here, Gwadar Pro reported on Tuesday. Under the flagship project of this cooperation, Pakistani and Chinese companies will jointly build a cancer medical laboratory. The agreement was jointly initiated and signed by Life Rehealth Technology Pakistan and Beijing Anlong Gene Medicine Technology.

Under the proposed framework, Pakistani and Chinese companies will jointly carry out exploration and research on cancer medical treatment, and Chinese companies will also share their existing medical technologies with Pakistan.

Dr Ahmed Waqas, the CEO of Life Rehealth, has been active in CPEC medical cooperation for a long-term. He said in an exclusive interview that, the incidence of cancer in Pakistan is very high, especially lung cancer, liver cancer and so on. However, due to the current medical level and sanitary conditions, patients cannot receive good treatments. Therefore, cooperation between Pakistan and China in this sector is very necessary and will bring great benefits to Pakistan.

Regarding the reasons why Pakistan chose Chinese company as cooperative partner, Waqas said, the cooperation in medical field is of great importance and requires profound friendship and trust between the two sides.